Compound details
Farnesyl pyrophosphate
| Compound ID | CDAMM00503 |
|---|---|
| Common name | Farnesyl pyrophosphate | IUPAC name | phosphono 3,7,11-trimethyldodeca-2,6,10-trienyl hydrogen phosphate |
| Molecular formula | C15H28O7P2 |
| Retention time | 10.33 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 383.14 | Theoretical mz | 383.138 |
| Error | 5.02 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.2589 |
| Inchi key | VWFJDQUYCIWHTN-YFVJMOTDSA-N |
|---|---|
| Smiles | O=P(O)(O)OP(=O)(O)OCC=C(C)CCC=C(C)CCC=C(C)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P48449 | LSS | Lanosterol synthase | T56175 | SEA |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction |
| O14842 | FFAR1 | Free fatty acid receptor 1 | T25608 | SwissTargetPrediction |
| Q14534 | SQLE | Squalene monooxygenase (by homology) | T93344 | SEA |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction and SEA |
| P41279 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | T00852 | SwissTargetPrediction |
| P25025 | CXCR2 | Interleukin-8 receptor B | T56923 | SwissTargetPrediction |
| P53609 | PGGT1B | Geranylgeranyl transferase type I | T76396 | SwissTargetPrediction and SEA |
| Q13526 | PIN1 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | T16308 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SEA |
| O95749 | GGPS1 | Geranyltranstransferase | T86528 | SEA |
| P53602 | MVD | Diphosphomevalonate decarboxylase | T96862 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T56175 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P48449 | LSS |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T25608 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O14842 | FFAR1 |
| T93344 | DI0118 | Dermatophytosis | [ICD-11: 1F28] | Q14534 | SQLE |
| T93344 | DI0385 | Skin fungal infection disorder | [ICD-11: EA60] | Q14534 | SQLE |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T00852 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P41279 | MAP3K8 |
| T56923 | DI0155 | Fungal infection | [ICD-11: 1F29-1F2F] | P25025 | CXCR2 |
| T56923 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25025 | CXCR2 |
| T76396 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P53609 | PGGT1B |
| T16308 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q13526 | PIN1 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T86528 | DI0057 | Bone paget disease | [ICD-11: FB85] | O95749 | GGPS1 |
| T86528 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | O95749 | GGPS1 |
| T86528 | DI0267 | Mineral excesses | [ICD-11: 5B91] | O95749 | GGPS1 |
| T86528 | DI0281 | Musculoskeletal disorder | [ICD-11: FA00-FC0Z] | O95749 | GGPS1 |